APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Andrographolide Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Andrographolide Tablets Industry Growth and Trends Forecast to 2032

Report ID 173963460126 December 202596 pages

Choose your research edition.

Industry ResearchAndrographolide Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Andrographolide Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Andrographolide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Andrographolide Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Andrographolide Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Andrographolide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Andrographolide Tablets include Guangdong Wannianqing Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Quanzhou Zhongqiao Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd. and Chongqing Kerui Pharmaceutical (Group) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Andrographolide Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Andrographolide Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Andrographolide Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Andrographolide Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Andrographolide Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Andrographolide Tablets Market by Company

Guangdong Wannianqing Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.

Henan Furentang Pharmaceutical Co., Ltd.

Hubei Keyi Pharmaceutical Co., Ltd.

Jiangxi Qingfeng Pharmaceutical Co., Ltd.

Quanzhou Zhongqiao Pharmaceutical Co., Ltd.

Wuxi Jiyushanwei Pharmaceutical Co., Ltd.

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Andrographolide Tablets Segment by Type

Dispersible Tablets

Conventional Tablets

Andrographolide Tablets Segment by Application

Hospital

Clinic

Other

Andrographolide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Andrographolide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Andrographolide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Andrographolide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Andrographolide Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Andrographolide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dispersible Tablets Table 2. Major Company of Conventional Tablets Table 3. Global Andrographolide Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Andrographolide Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Andrographolide Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Andrographolide Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Andrographolide Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Andrographolide Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Andrographolide Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Andrographolide Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Andrographolide Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Andrographolide Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Andrographolide Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Andrographolide Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Andrographolide Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Andrographolide Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Andrographolide Tablets Industry Trends Table 25. Andrographolide Tablets Industry Drivers Table 26. Andrographolide Tablets Industry Opportunities and Challenges Table 27. Andrographolide Tablets Industry Restraints Table 28. Global Andrographolide Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Andrographolide Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Andrographolide Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Andrographolide Tablets Sales Share by Company (2021-2026) Table 32. Global Andrographolide Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Andrographolide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Andrographolide Tablets Major Company Production Sites and Headquarters Table 35. Global Andrographolide Tablets Company, Product Type & Application Table 36. Global Andrographolide Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Andrographolide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Andrographolide Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Andrographolide Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Andrographolide Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Andrographolide Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Andrographolide Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Andrographolide Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Andrographolide Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Andrographolide Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Andrographolide Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Andrographolide Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Andrographolide Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Andrographolide Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Andrographolide Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Andrographolide Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Andrographolide Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Andrographolide Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Andrographolide Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Andrographolide Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Andrographolide Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Andrographolide Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Andrographolide Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Andrographolide Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Andrographolide Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information Table 72. Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview Table 73. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 75. Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Development Table 76. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 77. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 78. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 80. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 81. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information Table 82. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview Table 83. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio Table 85. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Development Table 86. Henan Furentang Pharmaceutical Co., Ltd. Company Information Table 87. Henan Furentang Pharmaceutical Co., Ltd. Business Overview Table 88. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 90. Henan Furentang Pharmaceutical Co., Ltd. Recent Development Table 91. Hubei Keyi Pharmaceutical Co., Ltd. Company Information Table 92. Hubei Keyi Pharmaceutical Co., Ltd. Business Overview Table 93. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 95. Hubei Keyi Pharmaceutical Co., Ltd. Recent Development Table 96. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information Table 97. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview Table 98. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 100. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Development Table 101. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information Table 102. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview Table 103. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 105. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Development Table 106. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information Table 107. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview Table 108. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 110. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Development Table 111. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 112. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 113. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio Table 115. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Development Table 116. North America Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 118. North America Andrographolide Tablets Sales Market Share by Country (2021-2026) Table 119. North America Andrographolide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Andrographolide Tablets Sales Market Share Forecast by Country (2027-2032) Table 121. North America Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Andrographolide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Andrographolide Tablets Market Share by Country (2021-2026) Table 124. North America Andrographolide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Andrographolide Tablets Market Share Forecast by Country (2027-2032) Table 126. Europe Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 128. Europe Andrographolide Tablets Sales Market Share by Country (2021-2026) Table 129. Europe Andrographolide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Andrographolide Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Andrographolide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Andrographolide Tablets Market Share by Country (2021-2026) Table 134. Europe Andrographolide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Andrographolide Tablets Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Andrographolide Tablets Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Andrographolide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Andrographolide Tablets Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Andrographolide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Andrographolide Tablets Market Share by Country (2021-2026) Table 144. Asia-Pacific Andrographolide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Andrographolide Tablets Market Share Forecast by Country (2027-2032) Table 146. Latin America Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 148. Latin America Andrographolide Tablets Sales Market Share by Country (2021-2026) Table 149. Latin America Andrographolide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Andrographolide Tablets Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Andrographolide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Andrographolide Tablets Market Share by Country (2021-2026) Table 154. Latin America Andrographolide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Andrographolide Tablets Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Andrographolide Tablets Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Andrographolide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Andrographolide Tablets Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Andrographolide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Andrographolide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Andrographolide Tablets Market Share by Country (2021-2026) Table 164. Middle East and Africa Andrographolide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Andrographolide Tablets Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Andrographolide Tablets Distributors List Table 169. Andrographolide Tablets Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Andrographolide Tablets Image Figure 2. Global Andrographolide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Andrographolide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Andrographolide Tablets Sales (2021-2032) & (K Units) Figure 5. Dispersible Tablets Image Figure 6. Global Dispersible Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Conventional Tablets Image Figure 8. Global Conventional Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Andrographolide Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Andrographolide Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Andrographolide Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Andrographolide Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Andrographolide Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Andrographolide Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Andrographolide Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Andrographolide Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Andrographolide Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Andrographolide Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Andrographolide Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Andrographolide Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Andrographolide Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Andrographolide Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Andrographolide Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Andrographolide Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Andrographolide Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Andrographolide Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Andrographolide Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Andrographolide Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Andrographolide Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Andrographolide Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Andrographolide Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Andrographolide Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Andrographolide Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Andrographolide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Andrographolide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Andrographolide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Andrographolide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Andrographolide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Andrographolide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Andrographolide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Andrographolide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Andrographolide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Andrographolide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Andrographolide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Andrographolide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Andrographolide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Andrographolide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Andrographolide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Andrographolide Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Andrographolide Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Dispersible Tablets
  • Conventional Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guangdong Wannianqing Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  • Henan Furentang Pharmaceutical Co., Ltd.
  • Hubei Keyi Pharmaceutical Co., Ltd.
  • Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  • Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  • Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Andrographolide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Andrographolide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Andrographolide Tablets Market by Type
  6. 1.3.1 Dispersible Tablets
  7. 1.3.2 Conventional Tablets
  8. 1.4 Global Andrographolide Tablets Market Size by Type
  9. 1.4.1 Global Andrographolide Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Andrographolide Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Andrographolide Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Andrographolide Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Andrographolide Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Andrographolide Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Andrographolide Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Andrographolide Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Andrographolide Tablets Industry Trends
  2. 2.2 Andrographolide Tablets Industry Drivers
  3. 2.3 Andrographolide Tablets Industry Opportunities and Challenges
  4. 2.4 Andrographolide Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Andrographolide Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Andrographolide Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Andrographolide Tablets Price (2021-2026)
  4. 3.4 Global Andrographolide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Andrographolide Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Andrographolide Tablets Company, Product Type & Application
  7. 3.7 Global Andrographolide Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Andrographolide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Andrographolide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Andrographolide Tablets Tier 1, Tier 2, and Tier 3
4 Andrographolide Tablets Regional Status and Outlook
  1. 4.1 Global Andrographolide Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Andrographolide Tablets Historic Market Size by Region
  3. 4.2.1 Global Andrographolide Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Andrographolide Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Andrographolide Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Andrographolide Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Andrographolide Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Andrographolide Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Andrographolide Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Andrographolide Tablets by Application
  1. 5.1 Andrographolide Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Andrographolide Tablets Market Size by Application
  6. 5.2.1 Global Andrographolide Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Andrographolide Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Andrographolide Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Andrographolide Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Andrographolide Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Andrographolide Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Andrographolide Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Andrographolide Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Guangdong Wannianqing Pharmaceutical Co., Ltd.
  2. 6.1.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  6. 6.1.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  8. 6.2.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  12. 6.2.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  14. 6.3.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
  15. 6.3.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview
  16. 6.3.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
  18. 6.3.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments
  19. 6.4 Henan Furentang Pharmaceutical Co., Ltd.
  20. 6.4.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Henan Furentang Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  24. 6.4.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Hubei Keyi Pharmaceutical Co., Ltd.
  26. 6.5.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Hubei Keyi Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  30. 6.5.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  32. 6.6.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  36. 6.6.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  38. 6.7.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  42. 6.7.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  44. 6.8.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  48. 6.8.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  50. 6.9.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  51. 6.9.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  52. 6.9.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
  54. 6.9.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Andrographolide Tablets Sales by Country
  2. 7.1.1 North America Andrographolide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Andrographolide Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Andrographolide Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Andrographolide Tablets Market Size by Country
  6. 7.2.1 North America Andrographolide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Andrographolide Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Andrographolide Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Andrographolide Tablets Sales by Country
  2. 8.1.1 Europe Andrographolide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Andrographolide Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Andrographolide Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Andrographolide Tablets Market Size by Country
  6. 8.2.1 Europe Andrographolide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Andrographolide Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Andrographolide Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Andrographolide Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Andrographolide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Andrographolide Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Andrographolide Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Andrographolide Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Andrographolide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Andrographolide Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Andrographolide Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Andrographolide Tablets Sales by Country
  2. 10.1.1 South America Andrographolide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Andrographolide Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Andrographolide Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Andrographolide Tablets Market Size by Country
  6. 10.2.1 South America Andrographolide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Andrographolide Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Andrographolide Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Andrographolide Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Andrographolide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Andrographolide Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Andrographolide Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Andrographolide Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Andrographolide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Andrographolide Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Andrographolide Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Andrographolide Tablets Value Chain Analysis
  2. 12.1.1 Andrographolide Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Andrographolide Tablets Production Mode & Process
  7. 12.2 Andrographolide Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Andrographolide Tablets Distributors
  10. 12.2.3 Andrographolide Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst